Work

A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer

Year: 2014

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-014-0142-1

Authors: Jaafar Bennouna, Marion Deslandres, Helene Senellart, Cecile de Labareyre, Rodrigo Ruiz-Soto, Claire Wixon, Jeff Botbyl, A. Benjamin Suttle, Jean-Pierre Delord

Institutions: Institut de Cancérologie de l'Ouest, Nantes Université, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline, Agence Nationale de la Recherche

Award: Cancer et Pharmacologie : Projet de Toulouse-Oncopole et de sa Région

OpenAlex ID: W1964513792

FWCI: 0.832

Cites: 30

Cited by: 26

Related to: 10